Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
(NASDAQ: AMLX) Delayed: 32.41 -1.53 (4.51%)
Previous Close $33.94    52 Week High $ 
Open $34.21    52 Week Low $ 
Day High $34.21    P/E N/A 
Day Low $32.25    EPS $ 
Volume 2,048,794